Nifedipine, a powerful antagonist of transmembrane calcium influx in cardiac cells (Fleckenstein et al., 1972) , has been found to be useful in the treatment of angina pectoris (Camerini et al., 1975) . In vitro studies have suggested that nifedipine has effects on atrioventricular nodal tissue similar to those of the other calcium antagonists, as exemplified by verapamil , though its action was more pronounced on coronary artery smooth muscle. However, work in the intact dog heart and observations of the surface electrocardiogram in patients receiving nifedipine have failed to show any significant depression of atrioventricular conduction (Ekelund and Oro, 1975; . If nifedipine does not depress intracardiac conduction, it may provide a useful alternative to the beta-blockers, particularly for patients with angina pectoris and pre-existing conduction abnormalities. The present study was undertaken to assess the effects of nifedipine administered intravenously during routine intracardiac electrophysiological studies and to compare these effects with those seen with verapamil during the same study.
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Received for publication 6 March 1979 Subjects and methods Eleven patients, the details of whom are shown in Table 1 , were studied during routine intracardiac electrophysiological investigations following the procedure previously described (Curry, 1975) . In 5 patients paroxysmal reciprocating atrioventricular tachycardia was shown to be associated with an accessory pathway (Wolff-Parkinson-White syndrome) which was overt in 4 patients and concealed in the other. Two further patients who also had paroxysmal reciprocating atrioventricular tachycardia were shown to have re-entry circuits confined close to or within the atrioventricular node (cases 6 and 7). The remaining 4 patients had paroxysmal atrial fibrillation or flutter conducted to the were measured before and 3 minutes after nifedipine. Verapamil (0-15 mg/kg body weight) was administered to 10 of the 11 patients 45 minutes after nifedipine, as an intravenous bolus and under the same circumstances as nifedipine had been given. The results after verapamil were then compared with those obtained after nifedipine. Table 2 shows the effect of nifedipine on sinus rate and atrioventricular nodal and His-Purkinje conduction times 5 minutes after administration. In all but 1 patient (case 7) there was a shortening in sinus cycle length but in no patient was there a significant change in atrioventricular nodal conduction. When given during paroxysmal reciprocating (Krikler and Spurrell, 1974) . Shortening of sinus cycle length after verapamil and nifedipine was of similar degree.
Results

Discussion
The calcium-ion antagonist verapamil has a powerful depressant effect on conduction through the atrioventricular node (Cranefield et al., 1974; Zipes and Fischer, 1974) . Fleckenstein et al. (1972) showed in vitro that nifedipine was a considerably more potent calcium-ion antagonist than verapamil on a weight-for-weight basis. However, , using an isolated dog atrioventricular node preparation, showed that the rate of blood flow through the atrioventricular nodal artery was about 10 times more sensitive to nifedipine than was the atrioventricular conduction time. This suggests that as coronary artery smooth muscle appeared to be far more susceptible to nifedipine than the cells that produce delay in atrioventricular nodal conduction, sufficient nifedipine to increase coronary blood flow might not slow atrioventricular nodal conduction. Furthermore, in the in situ paced hearts of open chest dogs nifedipine in a dose of 3 ,ug/kg intravenously facilitated atrioventricular nodal conduction if the heart had intact innervation, and also did not have a detrimental effect in the heart deprived of compensatory sympathetic drive by bilateral stellate ganglionectomy . This facilitating effect of nifedipine was therefore ascribed to a sympathetic mechanism triggered by peripheral vasodilatation and hypotension. At a higher dose level (30 Vg/kg) atrioventricular conduction was scarcely affected as long as the sympathetic nerve supply to the heart was intact, but after interruption of the sympathetic nerves both atrioventricular conduction time and the atrioventricular nodal functional refractory period were somewhat increased.
In clinical trials in man there have been no reports of adverse affects on atrioventricular conduction (Camerini et al., 1975; Ekelund and Oro, 1975) . The present investigation was designed to assess the effect of intravenous nifedipine on atrioventricular conduction in patients undergoing routine intracardiac studies. Previous work (Curry et al., 1978) has demonstrated the relation that exists between the electrophysiological properties of atrioventricular conduction and alteration in autonomic balance. The dose of nifedipine was 7-5 ,ug/kg body weight rather than 15 jig in order to avoid the increased sympathetic drive that accompanies the greater negative inotropic action of the larger dose (Lydtin et al., 1976) . Verapamil has been shown to exert a chronotropic action on sinus node activity by a baroreceptor-mediated increase in sympathetic tone (Breithardt et al., 1978) and the similarity in the degree of acceleration of sinus node discharge after both drugs suggests that their peripheral effects are similar. Thus in this dose it is unlikely that an electrophysiological action on atrioventricular conduction is cancelled by an increase in sympathetic tone secondary to a fall in arterial pressure. Comparing the resting basic cycle length and the AH and HV intervals measured during sinus rhythm before and 5 minutes after nifedipine the only change was an acceleration of the heart rate ( Table 2) .
The administration of a nodal depressant drug during re-entrant atrioventricular tachycardia when the circulating impulse continually depolarises the nodal cells when they are in a state of partial recovery may exaggerate effects not apparent during sinus rhythm. However, tachycardia was never terminated by nifedipine, and in only 1 patient did atrioventricular nodal conduction time lengthen, even then no more than had been seen spontaneously. A similar lack of effect was found during atrial pacing. However, as previously recognised, verapamil exerted a potent antiarrhythmic action in all patients (Schamroth et al., 1972;  Krikler and Spurrell, 1974) . The action of nifedipine given intravenously, as judged by haemodynamic changes in healthy volunteers and patients with ischaemic heart disease, does not appear to exceed 15 minutes (Lydtin et al., 1975 
